• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: experience of the BFM study 86.

作者信息

Ludwig W D, Harbott J, Bartram C R, Komischke B, Sperling C, Teichmann J V, Seibt-Jung H, Notter M, Odenwald E, Nehmer A

机构信息

Department of Hematology and Oncology, Klinikum Steglitz, Free University of Berlin, Fed. Rep. of Germany.

出版信息

Recent Results Cancer Res. 1993;131:269-82. doi: 10.1007/978-3-642-84895-7_24.

DOI:10.1007/978-3-642-84895-7_24
PMID:8210646
Abstract
摘要

相似文献

1
Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: experience of the BFM study 86.
Recent Results Cancer Res. 1993;131:269-82. doi: 10.1007/978-3-642-84895-7_24.
2
Incidence, clinical and laboratory features, and prognostic significance of immunophenotypic subgroups in acute lymphoblastic leukemia: the GEIL experience.
Recent Results Cancer Res. 1993;131:283-95. doi: 10.1007/978-3-642-84895-7_25.
3
[Incidence, clinical markers and prognostic significance of immunologic subtypes of acute lymphoblastic leukemia (ALL) in children: experiences of the ALL-BFM 83 and 86 studies].儿童急性淋巴细胞白血病（ALL）免疫亚型的发病率、临床标志物及预后意义：ALL-BFM 83和86研究经验
Klin Padiatr. 1990 Jul-Aug;202(4):243-52. doi: 10.1055/s-2007-1025528.
4
Childhood acute lymphoblastic leukemia immunophenotypes and their prognostic significance: experience of the IGCI-study in 389 children. International Society for Chemo-immunotherapy (IGCI-Vienna) Cooperative Group.儿童急性淋巴细胞白血病免疫表型及其预后意义：国际化疗免疫治疗学会（IGCI-维也纳）合作组对389例儿童的研究经验
Leuk Lymphoma. 1992 Jun;7(3):225-34. doi: 10.3109/10428199209053627.
5
Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: the experience of the AIEOP Cooperative Study. Associazione Italiana Ematologia Oncologia Pediatrica.
Recent Results Cancer Res. 1993;131:297-307. doi: 10.1007/978-3-642-84895-7_26.
6
Use of clinical and laboratory features to define prognostic subgroups in B-precursor acute lymphoblastic leukemia: experience of the Pediatric Oncology Group.利用临床和实验室特征定义B前体急性淋巴细胞白血病的预后亚组：儿科肿瘤学组的经验
Recent Results Cancer Res. 1993;131:257-67. doi: 10.1007/978-3-642-84895-7_23.
7
Immunologic subclassification of acute lymphoblastic leukemia in childhood and prognosis (modified BFM protocol).儿童急性淋巴细胞白血病的免疫学分型与预后（改良BFM方案）
Haematol Blood Transfus. 1989;32:109-12. doi: 10.1007/978-3-642-74621-5_18.
8
Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies.髓系标志物的表达对接受急性淋巴细胞白血病治疗的儿童无预后影响：意大利在AIEOP-ALL 88-91研究中的经验。
Blood. 1998 Aug 1;92(3):795-801.
9
Molecular and clinical prognostic factors in BFM-treated childhood acute lymphoblastic leukemia patients: a single institution series.柏林-法兰克福-明斯特（BFM）方案治疗的儿童急性淋巴细胞白血病患者的分子和临床预后因素：单中心研究系列
Haematologica. 2000 Aug;85(8):877-8.
10
Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.miR-143/miR-182 水平在 BFM 治疗儿童急性淋巴细胞白血病预后和危险分层特异性中的临床应用
Ann Hematol. 2018 Jul;97(7):1169-1182. doi: 10.1007/s00277-018-3292-y. Epub 2018 Mar 20.

引用本文的文献

1
Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary Trials.当代试验中 T 细胞 ALL 及诱导失败患儿和青年患者的结局。
J Clin Oncol. 2023 Nov 10;41(32):5025-5034. doi: 10.1200/JCO.23.00088. Epub 2023 Jul 24.
2
Interleukin-3 receptor α chain (CD123) is preferentially expressed in immature T-ALL and may not associate with outcomes of chemotherapy.白细胞介素-3受体α链（CD123）在不成熟的T细胞急性淋巴细胞白血病中优先表达，且可能与化疗结果无关。
Tumour Biol. 2016 Mar;37(3):3817-21. doi: 10.1007/s13277-015-3272-y. Epub 2015 Oct 16.